• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Break (1069); Material Fragmentation (1261)
Patient Problems Pain (1994); Rash (2033); Device Embedded In Tissue or Plaque (3165)
Event Type  malfunction  
Event Description
This spontaneous case was reported by a lawyer and describes the occurrence of device breakage ("essure fragments") in a female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patient had essure inserted.On an unknown date, the patient experienced device breakage (seriousness criterion medically significant), rash ("rash/ liver rash") and pain ("sores").At the time of the report, the device breakage, rash and pain outcome was unknown.The reporter considered device breakage, pain and rash to be related to essure.Concerning the injuries reported in this case, the following ones were reported via social media: device breakage, rash, pain.Incident : no lot number or sample available for investigation.There is no evidence that a device related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
Ntaneous case was reported by a lawyer and describes the occurrence of device breakage ("essure fragments") in a female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patient had essure inserted.On an unknown date, the patient experienced device breakage (seriousness criterion medically significant), rash ("rash/sores"), pain ("sores") and liver disorder ("liver rash").At the time of the report, the device breakage, rash, pain and liver disorder outcome was unknown.The reporter considered device breakage, liver disorder, pain and rash to be related to essure.The reporter commented: the consumer described that she got to have a liver panel testing.Concerning the injuries reported in this case, the following one/ones were reported via social media: device breakage, rash, pain.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 30-oct-2018: quality safety evaluation of product technical complaint.No lot number or sample available for investigation.There is no evidence that a device related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
This spontaneous case was reported by a lawyer and describes the occurrence of device breakage ("essure fragments") in a female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patient had essure inserted.On an unknown date, the patient experienced device breakage (seriousness criterion medically significant), rash ("rash/sores"), pain ("sores") and liver disorder ("liver rash").At the time of the report, the device breakage, rash, pain and liver disorder outcome was unknown.The reporter considered device breakage, liver disorder, pain and rash to be related to essure.The reporter commented: the consumer described that she got to have a liver panel testing.Concerning the injuries reported in this case, the following one/ones were reported via social media: device breakage, rash, pain.Most recent follow-up information incorporated above includes: on 28-jun-2018: correction following company internal coding review.The event rash/ liver rash was changed to rash/sores and an event liver rash was created.In addition an reporter comment was added.Incident: no lot number or sample available for investigation.There is no evidence that a device related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
MDR Report Key7643219
MDR Text Key112861713
Report Number2951250-2018-02867
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup,Followup
Report Date 10/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberESS305
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received10/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-